Our science

Restoration without replacement.

We study how memory can recover while identity, context, and the capacity to revise remain part of the person who returns.

The research question

How do you restore access without deciding who someone should become?

Memory is not a library of files. It is a living process: a network of biological traces, emotional context, competing associations, and pathways that change each time we recall.

Clarity+ combines biological readout with predictive state estimation and guided reconsolidation. The goal is not to install an answer. It is to help the brain regain access to pathways that disease has made unstable.

The platform

Four disciplines, one continuous model.

Each layer contributes a different kind of evidence. No single signal is treated as the whole person.

Selective activity-dependent signals within living neural tissue

Activity-dependent readout

NeuroTag priming helps identify biological activity associated with guided recall over time.

Neurobiology

An individualized neural state model assembled from high-density sensing

Individual state estimation

High-density sensing and head modeling estimate active pathways in the context of one person's recall.

Computational modeling

Multiple neural pathways held within a carefully constrained stability window

Stability-window control

Targeted suppression and a personalized field support reconsolidation without treating every deviation as error.

Clinical neuroscience

A five-module home interface connected to an individualized clinical care pathway

Continuity by design

Hardware limits, profile verification, and controlled maintenance keep the individual plan connected across settings.

Engineering R&D

The Ellison Continuity Constraint

A person must retain more than one viable pathway.

Vale Biotech co-founder Dr. Robert Ellison established a simple boundary for restorative systems: contradiction, ambivalence, and the freedom to revise are not noise to be optimized away.

Identity is not a single best answer. Continuity depends on preserving the capacity for another answer to remain possible.

Read our founding story

From model to medicine

Built for the distance between a signal and a person.

Research, engineering, and clinical teams work side by side so every model remains connected to observable care.

Researchers working in a functional Vale Biotech neuroscience lab — Research laboratoryIndividual mapping and state estimation

Vale Biotech clinical treatment suite with a high-contact cranial array — Clinical treatment suiteSupervised guided reconsolidation

Engineering the boundary

Safety lives in what the system cannot negotiate around.

Verified individual targets

The active plan must match the enrolled profile prepared during mapping and onboarding.

Physical dose limits

Clinical hardware boundaries operate independently from treatment software.

Independent abort paths

Supervised intervention includes a local path designed to stop outside software control.

Continuous observation

Clinical decisions remain tied to patient response, not a model in isolation.

See the platform in practice

From the stability window to Clarity+ Home.

Explore how the research becomes one connected, individualized course of care.

Explore Clarity+